Pharmacotherapy in pigeons and cage and aviary birds

The costs of research and development to meet the increasing number of requirements for quality, safety and efficacy of veterin

ary medicines are causing a gradual reduction in the supply of authorised medicines for species and therapeutic indications of lesser economic importance. It is becoming increasingly difficult, especially for minor species such as pigeons and cage and aviary birds, to obtain suitable medicines within the legal provisions.